-
71تقرير
المصدر: A Comparative Study on the Accuracy, Ease of Use and Skin Reactions Between the Enlite Sensor With Guardian 2 Link Transmitter and the FreeStyle Libre Flash Glucose Sensor
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03249974Test
-
72تقرير
المصدر: Evaluating Glucose Control in Patients With Type 1 Diabetes Under Free-living Conditions With the Insulet Automated Glucose Control System: IDE3
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03216460Test
-
73تقرير
المساهمون: Annesofie Lunde Jensen, Clinical nursespecialist postdoc
المصدر: DiabetesFlex - Patient Involvement and Patient-reported Outcome Measures in Type 1 Diabetes: A Randomised Controlled Trial and Interview Study
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03202732Test
-
74تقرير
المصدر: A Euglycaemic Clamp Trial to Evaluate the Pharmacokinetic and Pharmacodynamic Properties of a Bolus Dose of BioChaperone® Insulin Lispro, Fiasp® and NovoRapid® by an Insulin Pump
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03179332Test
-
75تقرير
المؤلفون: Integrium
المصدر: A Randomized Controlled Trial Comparing 21 Days of Continuous Subcutaneous Insulin Infusion (CSII) Using Hepatic Directed Vesicle (HDV) Insulin to Standard CSII in Type 1 Diabetes Mellitus
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03156361Test
-
76تقرير
المؤلفون: CHU de Quebec-Universite Laval
المساهمون: Dr. Steven Paraskevas, Associate Professor of Surgery
المصدر: Immune Response to Extracellular Vesicles Released by Human Islets of Langerhans
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03106246Test
-
77تقرير
المصدر: A Randomized, Placebo-controlled, Double-blind Study to Evaluate the Efficacy, Safety, and Pharmacodynamics of Multiple Doses of REMD-477 in Subjects With Type 1 Diabetes Mellitus
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03117998Test
-
78تقرير
المؤلفون: TypeZero Technologies, Inc., Novo Nordisk A/S, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), DexCom, Inc.
المصدر: Bisio A, Anderson S, Norlander L, O'Malley G, Robic J, Ogyaadu S, Hsu L, Levister C, Ekhlaspour L, Lam DW, Levy C, Buckingham B, Breton MD. Impact of a Novel Diabetes Support System on a Cohort of Individuals With Type 1 Diabetes Treated With Multiple Daily Injections: A Multicenter Randomized Study. Diabetes Care. 2022 Jan 1;45(1):186-193. doi: 10.2337/dc21-0838.
Efficacy of inControl Advice: A Decision Support System (DSS) for Diabetesالوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03093636Test
-
79تقرير
المساهمون: Zhiguang Zhou, Principal Investigator
المصدر: Mward K, sa F, Hester J, Fueroa-TentorD, Madral A, Wood KJ. Multle un pooled umbal cord blood a vble source of therapeut regulatory T cells. Transplantatn. 2013 Jan 15;95(1):85-93. do 10.1097/TP.0b013e31827722ed.
Fan H, Yang J, Hao J, Ren Y, Chen L, LG, X R, Yang Y, Gao F, L M. Comparate study of regulatory T cells expanded ex vo from cord blood and adult perheral blood. munology. 2012 Jun;136(2):218-30. do 10.1111/j.1365-2567.2012.03573.x.
Brunste CG, Mler JS, Cao Q, McKenna DH, Hpen KL, Curtsger J, Defor T, Leve BL, June CH, Rubste P, McGlave PB, Blazar BR, Wagner JE. fusn of ex vo expanded T regulatory cells adults transplanted wh umbal cord blood: safety profe and detectn kets. Blood. 2011 Jan 20;117(3):1061-70. do 10.1182/blood-2010-07-293795. Epub 2010 Oct 15.
Rondas D, D'Hertog W, Overbergh L, Mathu C. Glucagon-le pepte-1: modulator of beta-cell dysfunctn and death. Dbetes Obes Metab. 2013 Sep;15 Suppl 3:185-92. do 10.1111/dom.12165.
Chang TJ, Tseng HC, L MW, Chang YC, Hsh ML, Chuang LM. Glucagon-le pepte-1 prevents methylglyoxal-duced apoptos of beta cells through provg mochondrl functn and suppressg prolonged AMPK actatn. ScRep. 2016 Mar 21;6:23403. do 10.1038/srep23403. Erratum : ScRep. 2016 May 31;6:26917.
Zoso A, SerafP, LanzonG, Peoto E, Messger S, Mantero A, Padla-Tellez ND, Baal DA, Alejandro R, RordC, verardL. G-CSF and Exenate Mht Be Assocted wh creased Long-Term Surval of Allogene Pancreat let Grafts. PLoS One. 2016 Jun 10;11(6):e0157245. do 10.1371/journal.pone.0157245. eCollectn 2016.
Phase 1/ Phase 2 Study of the Therapeutic Effect of Ex-vivo Expanded Umbilical Cord Blood Regulatory T Cells With Liraglutide on Autoimmune Diabetesالوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03011021Test
-
80تقرير
المؤلفون: Illinois Institute of Technology
المساهمون: Michael Riddell, Professor
المصدر: Iscoe KE, Riddell MC. Continuous moderate-intensity exercise with or without intermittent high-intensity work: effects on acute and late glycaemia in athletes with Type 1 diabetes mellitus. Diabet Med. 2011 Jul;28(7):824-32. doi: 10.1111/j.1464-5491.2011.03274.x.
Guelfi KJ, Ratnam N, Smythe GA, Jones TW, Fournier PA. Effect of intermittent high-intensity compared with continuous moderate exercise on glucose production and utilization in individuals with type 1 diabetes. Am J Physiol Endocrinol Metab. 2007 Mar;292(3):E865-70. doi: 10.1152/ajpendo.00533.2006.
Yardley JE, Sigal RJ. Exercise strategies for hypoglycemia prevention in individuals with type 1 diabetes. Diabetes Spectr. 2015 Jan;28(1):32-8. doi: 10.2337/diaspect.28.1.32.
The Effects of Basal Insulin Suspension at the Start of Exercise on Blood Glucose Levels During Continuous vs. Circuit-based Exercise in Individuals With Type 1 Diabetes on CSIIالوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03034798Test